Perception of COVID-19 Testing in the Entire Population

被引:1
作者
Gavurova, Beata [1 ]
Ivankova, Viera [1 ]
Rigelsky, Martin [2 ]
Caha, Zdenek [3 ]
Mudarri, Tawfik [1 ]
机构
[1] Tech Univ Kosice, Inst Earth Resources, Fac Min Ecol Proc Control & Geotechnol, Kosice, Slovakia
[2] Univ Presov, Fac Management & Business, Dept Mkt & Int Trade, Presov, Slovakia
[3] Inst Technol & Business Ceske Budejovice, Fac Corp Strategy, Dept Human Resource Management, Ceske Budejovice, Czech Republic
关键词
pandemic; political decision-making; interventions; mass testing; behavior; gender; age; social attitudes; PUBLIC-HEALTH;
D O I
10.3389/fpubh.2022.757065
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In the Slovak Republic, a mass testing of the entire population was performed. Estimates show that this testing cost more than 400 million EUR and thousands of euros were paid for one positively identified case. Thus, it is possible to state a high cost for such a project, which has been criticized by many parties. On the other hand, from a public health point of view, mass testing has helped fight the pandemic. Both the health and economic perspectives are important in assessing the success of a pandemic strategy, but the social perspective is equally important. In fact, the situation is perceived from the position of public leaders who make decisions, but also from the position of the society that bears individual political decisions. It is not appropriate to forget about the society that is most affected by restrictions, testing, health status, but also the burden on the state budget. The objective of the presented research was to examine the perception of testing for coronavirus disease 2019 (COVID-19) in the Slovak population. Non-parametric difference tests and correspondence analysis were used for statistical processing. The research sample consisted of 806 respondents and data collection took place in February 2021. The main findings include significant differences in perceptions between the first and the last participation in testing in terms of gender, age, testing experience, and time aspect. The last participation in testing showed lower rates of positive aspects related to the internal motivation to test compared to the first participation. In contrast, external stimulation by government regulations related to restrictions in the absence of a negative result was higher in the last participation in testing. There were also differences between the first and the last test in the level of doubts about the accuracy of the test result, while a higher level was found at the last testing participation. It can be concluded that the frequency of testing and its requirements need to be approached very carefully over time, as it is likely that the positive perceptions may deteriorate. The recommendations include clear and timely government communication, trust building and health education.
引用
收藏
页数:14
相关论文
共 49 条
  • [1] Communicating test results in a comprehensible manner: A randomized controlled trial of word usage in doctor-patient communication
    Auschra, Carolin
    Moller, Jana
    Berthod, Olivier
    Mazheika, Yuliya
    Borusiak, Peter
    [J]. ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2020, 156-157 : 40 - 49
  • [2] Besenyo J., 2020, Insights into Regional Development, V2, P630, DOI [10.9770/IRD.2020.2.3(2), DOI 10.9770/IRD.2020.2.3(2)]
  • [3] Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study
    Blake, Holly
    Corner, Jessica
    Cirelli, Cecilia
    Hassard, Juliet
    Briggs, Lydia
    Daly, Janet M.
    Bennett, Malcolm
    Chappell, Joseph G.
    Fairclough, Lucy
    McClure, C. Patrick
    Tarr, Alexander
    Tighe, Patrick
    Favier, Alex
    Irving, William
    Ball, Jonathan
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (01) : 1 - 26
  • [4] The impact of COVID-19 social isolation on aspects of emotional and social cognition
    Bland, Amy Rachel
    Roiser, Jonathan Paul
    Mehta, Mitul Ashok
    Sahakian, Barbara Jacquelyn
    Robbins, Trevor William
    Elliott, Rebecca
    [J]. COGNITION & EMOTION, 2022, 36 (01) : 49 - 58
  • [5] Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France
    Bosetti, Paolo
    Kiem, Cecile Tran
    Yazdanpanah, Yazdan
    Fontanet, Arnaud
    Lina, Bruno
    Colizza, Vittoria
    Cauchemez, Simon
    [J]. EUROSURVEILLANCE, 2021, 26 (01) : 8 - 14
  • [6] Briestensky R., 2019, Adiktologie, P203, DOI [10.35198/01-2019-004-0004, DOI 10.35198/01-2019-004-0004]
  • [7] Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results
    Caruana, G.
    Croxatto, A.
    Coste, A. T.
    Opota, O.
    Lamoth, F.
    Jaton, K.
    Greub, G.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (09) : 1178 - 1182
  • [8] Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2
    Cerutti, Francesco
    Burdino, Elisa
    Milia, Maria Grazia
    Allice, Tiziano
    Gregori, Gabriella
    Bruzzone, Bianca
    Ghisetti, Valeria
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2020, 132
  • [9] Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand
    Chaimayo, Chutikarn
    Kaewnaphan, Bualan
    Tanlieng, Nattaya
    Athipanyasilp, Niracha
    Sirijatuphat, Rujipas
    Chayakulkeeree, Methee
    Angkasekwinai, Nasikarn
    Sutthent, Ruengpung
    Puangpunngam, Nattawut
    Tharmviboonsri, Theerawoot
    Pongraweewan, Orawan
    Chuthapisith, Suebwong
    Sirivatanauksorn, Yongyut
    Kantakamalakul, Wannee
    Horthongkham, Navin
    [J]. VIROLOGY JOURNAL, 2020, 17 (01)
  • [10] Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce Outbreaks
    Chin, Elizabeth T.
    Huynh, Benjamin Q.
    Chapman, Lloyd A. C.
    Murrill, Matthew
    Basu, Sanjay
    Lo, Nathan C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E3127 - E3129